Pascolizumab Biosimilar, Anti-human IL-4 Antibody | C059P
$175.00 – $960.00
The cheapest research grade pascolizumab biosimilar (anti-human anti-interleukin-4 (IL-4) monoclonal antibody, mAb) for ELISA, neutralization, in vivo functional assays such as bioanalytical PK and ADA assays, and those in vitro and in vivo assays for studying biological pathways affected by pascolizumab. The research grade pascolizumab biosimilar protein is for research use only.
Synonyms: interleukin 4, IL4, IL-4
- Details & Specifications
- References
- More Offers
| Catalog No. | C059P |
|---|---|
| Product Name | Pascolizumab Biosimilar, Anti-human IL-4 Antibody | C059P |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Source/Host | The anti-human Interleukin-4 (IL-4) monoclonal antibody pascolizumab biosimilar was produced in mammalian cells. |
| Specificity/Sensitivity | The in vivo grade pascolizumab biosimilar specifically binds to the human Interleukin-4 (IL-4). |
| Form Of Antibody | 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives. |
| Endotoxin | < 0.1 EU per 1 ug of the protein by the LAL method. |
| Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
| Shipping | The research grade pascolizumab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
| Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com Or leave a message with a formal purchase order (PO) Or credit card. |
Description
C059P: Pascolizumab Biosimilar (Research Grade), Anti-human IL-4 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Background
What is Mirvetuximab biosimilar research grade? Mirvetuximab biosimilar uses the same protein sequences as the therapeutic antibody Mirvetuximab. Mirvetuximab soravtansine is used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Mirvetuximab soravtansine is a folate receptor alpha (FRa)-directed antibody and microtubule inhibitor conjugate.
Syd Labs provides the following research grade antibody biosimilars used in ADCs:
Tusamitamab biosimilar, research grade, anti-human CEACAM5 monoclonal antibody
Rovalpituzumab biosimilar, research grade, anti-human DLL3 monoclonal antibody
Trastuzumab biosimilar, research grade, anti-human HER2 monoclonal antibody
Cofetuzumab biosimilar, research grade, anti-human PTK7 monoclonal antibody
Ifinatamab biosimilar, research grade, anti-human B7-H3 (CD276) monoclonal antibody
Sacituzumab biosimilar, research grade, anti-human Trop-2 monoclonal antibody
Gemtuzumab biosimilar, research grade, anti-human CD33 monoclonal antibody
Polatuzumab biosimilar, research grade, anti-human CD79B monoclonal antibody
Cetuximab biosimilar, research grade, anti-human EGFR monoclonal antibody
Pascolizumab Biosimilar from: Pascolizumab Biosimilar, Anti-human IL-4 Antibody: C059P Syd Labs

